Poor Response to Bevacizumab Correlates With Higher IL-6 and IL-8 Aqueous Cytokines in AMD. Connolly E, El-Farouki G, Brennan K, Cahill M, et al. Invest Ophthalmol Vis Sci 2024;65:37.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Connolly E, El-Farouki G, Brennan K, Cahill M, et al. Poor Response to Bevacizumab Correlates With Higher IL-6 and IL-8 Aqueous Cytokines in AMD. Invest Ophthalmol Vis Sci 2024;65:37.
PMID: 39325472